Literature DB >> 8102576

Dinucleotide repeat polymorphism in the human CD40 ligand gene.

R C Allen1, M K Spriggs, J W Belmont.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8102576     DOI： 10.1093/hmg/2.6.828-a

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN： 0964-6906            Impact factor:   6.150


× No keyword cloud information.
  10 in total

Review 1.  The biology of the human ligand for CD40.

Authors:  M K Spriggs; W C Fanslow; R J Armitage; J Belmont
Journal:  J Clin Immunol       Date:  1993-11       Impact factor: 8.317

2.  Linkage of cytokine genes to rheumatoid arthritis. Evidence of genetic heterogeneity.

Authors:  S John; A Myerscough; A Marlow; A Hajeer; A Silman; W Ollier; J Worthington
Journal:  Ann Rheum Dis       Date:  1998-06       Impact factor: 19.103

Review 3.  The hyper-IgM (HIM) syndrome.

Authors:  N Ramesh; M Seki; L D Notarangelo; R S Geha
Journal:  Springer Semin Immunopathol       Date:  1998

4.  Parental origin of the extra chromosomes in polysomy X.

Authors:  C A Leal; J W Belmont; R Nachtman; J M Cantu; C Medina
Journal:  Hum Genet       Date:  1994-10       Impact factor: 4.132

Review 5.  Molecular and genetic basis of X-linked immunodeficiency disorders.

Authors:  J M Puck
Journal:  J Clin Immunol       Date:  1994-03       Impact factor: 8.317

6.  Application of carrier testing to genetic counseling for X-linked agammaglobulinemia.

Authors:  R C Allen; R G Nachtman; H M Rosenblatt; J W Belmont
Journal:  Am J Hum Genet       Date:  1994-01       Impact factor: 11.025

7.  A single strand conformation polymorphism study of CD40 ligand. Efficient mutation analysis and carrier detection for X-linked hyper IgM syndrome.

Authors:  Q Lin; J Rohrer; R C Allen; M Larché; J M Greene; A O Shigeoka; R A Gatti; D C Derauf; J W Belmont; M E Conley
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

8.  Immunoprinting: various genes are associated with increased risk to develop rheumatoid arthritis in different groups of adult patients.

Authors:  M Gomolka; H Menninger; J E Saal; E M Lemmel; E D Albert; O Niwa; J T Epplen; C Epplen
Journal:  J Mol Med (Berl)       Date:  1995-01       Impact factor: 4.599

Review 9.  X-linked immunodeficiency with hyper-IgM (XHIM).

Authors:  L D Notarangelo; A R Hayward
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

Review 10.  X-linked hyper IgM syndrome.

Authors:  L C Schneider
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 10.817
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.